Desmoplastic infantile ganglioglioma

Desmoplastic infantile ganglioglioma (DIG) is a rare, benign brain tumor that primarily affects infants and young children. It is classified as a World Health Organization (WHO) Grade I tumor, indicating a low potential for malignancy. DIG is characterized by a combination of neuronal and glial cell components, along with a prominent desmoplastic (fibrous) stroma.

Clinical Presentation

Patients with desmoplastic infantile ganglioglioma typically present with symptoms related to increased intracranial pressure, such as vomiting, irritability, and macrocephaly. Seizures are also a common presenting symptom. The age of onset is usually within the first two years of life.

Pathology

Macroscopically, DIGs are large, cystic tumors with a solid component. Microscopically, they exhibit a mixture of ganglion cells, astrocytes, and a dense desmoplastic stroma. The presence of both neuronal and glial elements is a hallmark of this tumor type. Immunohistochemical staining often shows positivity for markers such as synaptophysin, neurofilament, and glial fibrillary acidic protein (GFAP).

Diagnosis

The diagnosis of desmoplastic infantile ganglioglioma is typically made through a combination of neuroimaging and histopathological examination. Magnetic resonance imaging (MRI) usually reveals a large, cystic mass with a solid component. Computed tomography (CT) scans may show calcifications within the tumor. Definitive diagnosis is confirmed through biopsy and subsequent histological analysis.

Treatment

The primary treatment for DIG is surgical resection. Complete removal of the tumor often results in a favorable prognosis. In cases where complete resection is not possible, additional treatments such as chemotherapy or radiation therapy may be considered, although their roles are not well established due to the tumor's rarity and generally benign nature.

Prognosis

The prognosis for patients with desmoplastic infantile ganglioglioma is generally good, especially when complete surgical resection is achieved. Recurrence is uncommon, and long-term survival rates are high. However, close follow-up is necessary to monitor for any signs of recurrence or complications.

Related Pages

• Brain tumor
• Neuronal tumor
• Glial cell
• Intracranial pressure
• Seizure
• Magnetic resonance imaging
• Computed tomography
• Surgical resection

External Links

‎